Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

841 studies match

clinicaltrialsPublishedShowing 51–100 of 841 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03564340	Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers	recruiting	Phase 1 / Phase 2	890	Regeneron PharmaceuticalsINDUSTRY	10	Sep 25, 2026	clinicaltrials
NCT04094610	A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations	recruiting	Phase 1 / Phase 2	75	Turning Point Therapeutics, Inc.INDUSTRY	11	Sep 25, 2026